CORONA Remedies Limited has informed the Exchange regarding 'Commencement of Commercial Production'.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Corona Remedies Limited has informed the exchange that it has commenced commercial production, likely at a new manufacturing facility or an expanded product line. The company, which operates in the pharmaceutical sector, has not disclosed specific revenue projections or order details tied to this production start in this filing. This is a routine regulatory disclosure indicating that a previously announced capacity addition or new plant is now operational.
Positive operational milestone signalling that new capacity is contributing to revenue, but without disclosed order or revenue figures, the immediate stock impact is likely to be limited. Shareholders should look for upcoming quarterly results to gauge the financial contribution of this new production.